Nikola Minovski

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Antibiotics (Basel, Switzerland)

Journal of medicinal chemistry

International journal of molecular sciences

ACS omega

National Institute of Chemistry

National Institute of Chemistry (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute of Chemistry

Slovenia

Researcher :: Theory Department, Laboratory for Cheminformatics

Education History

National Institute of Chemistry Oct 04 2007

Slovenia

PHD :: Theory Department, Laboratory for Cheminformatics

Faculty of Pharmacy

North Macedonia

MSC :: Pharmaceutical & Medicinal Chemistry

Publications

Maja Kokot, Nikola Minovski
Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations. ACS omega 9 (16) (2024)
Maja Kokot, Nikola Minovski
Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations. ACS omega 9 (16) (2024)
Maja Kokot, Doroteja Novak, Irena Zdovc, Marko Anderluh, Martina Hrast Rambaher, Nikola Minovski
Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Maja Kokot, Marko Anderluh, Martina Hrast, Nikola Minovski
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV. Journal of medicinal chemistry 65 (9) (2022)
Anja Kolarič, Maja Kokot, Martina Hrast Rambaher, Matjaž Weiss, Irena Zdovc, Jurij Trontelj, Simon Žakelj, Marko Anderluh, Nikola Minovski
A Fine-Tuned Lipophilicity/Hydrophilicity Ratio Governs Antibacterial Potency and Selectivity of Bifurcated Halogen Bond-Forming NBTIs. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Maja Kokot, Matjaž Weiss, Irena Zdovc, Martina Hrast, Marko Anderluh, Nikola Minovski
Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity. ACS medicinal chemistry letters 12 (9) (2021)
Anja Kolarič, Thomas R M Germe, Martina Hrast Rambaher, Clare E M Stevenson, David M Lawson, Nicolas P Burton, Judit Vörös, Anthony Maxwell, Nikola Minovski, Marko Anderluh
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds. Nature communications 12 (1) (2021)
Liadys Mora Lagares, Yunierkis Perez Castillo, Nikola Minovski, Marjana Novič
Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations. International journal of molecular sciences 23 (1) (2021)
Liadys Mora Lagares, Nikola Minovski, Ana Yisel Caballero Alfonso, Emilio Benfenati, Sara Wellens, Maxime Culot, Fabien Gosselet, Marjana Novič
Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. International journal of molecular sciences 21 (11) (2020)
Anja Kolarič, Marko Anderluh, Nikola Minovski
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs). Journal of medicinal chemistry 63 (11) (2020)
Liadys Mora Lagares, Nikola Minovski, Marjana Novič
Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds. Molecules (Basel, Switzerland) 24 (10) (2019)

Nikola Minovski.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nikola Minovski